{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2019"],"condition":["colorectal cancer liver metastases"],"disease":["Colorectal Cancer Liver Metastases"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2688048"],"location":["China"],"study_start_month":["10"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"A multi-center prospective randomized study on postoperative hepatic arterial chemotherapy combined with systemic chemotherapy as adjuvant treatment after resection of colorectal liver metastases","description":"Interventions: experimental group:FOLFOX +HAI;control group:2 years postoperative recurrence rate\nPrimary outcome(s): 2-year recurrence rate and 2-year intrahepatic recurrence rate\nStudy Design: Parallel","dates":{"creation":"2019-10-15"},"accession":"2688048","cross_references":{"Chinese Clinical Trial Register":["ChiCTR1900027090"]}}